Again the big question WHY HAS FMS BOARD NOT FURTHERED A DEAL FOR INFRASTRUCTURE SOLUTION WITH BBI considering our major shareholder owns this planned infrastructure ???? which would advantage all shareholders and enormously affect our share price. Maybe an article surrounding this question would be in line also pointing highly out to all that if this was done delisting would not be reasonable.
- Forums
- ASX - By Stock
- RHK
- Ann: TOV: Panel Receives Review Application
Ann: TOV: Panel Receives Review Application, page-21
Featured News
Add RHK (ASX) to my watchlist
|
|||||
Last
84.5¢ |
Change
0.040(4.97%) |
Mkt cap ! $168.8M |
Open | High | Low | Value | Volume |
84.5¢ | 84.5¢ | 84.5¢ | $95 | 112 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5 | 80.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
88.0¢ | 10355 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5 | 0.805 |
1 | 3035 | 0.800 |
1 | 2531 | 0.770 |
1 | 16200 | 0.760 |
2 | 5573 | 0.740 |
Price($) | Vol. | No. |
---|---|---|
0.880 | 10355 | 1 |
0.890 | 2368 | 1 |
0.910 | 20000 | 1 |
0.980 | 10000 | 1 |
1.000 | 1812 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
RHK (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online